Sensa supports weight-loss claims
This article was originally published in The Tan Sheet
Executive SummarySupplement marketer Sensa Products substantiates claims its weight-loss product Sensa "works with your body's natural impulses" and "was proven effective in one of the largest clinical studies ever performed on a non-prescription weight-loss product," the National Advertising Division says in a report Sept. 3. The Council of Better Business Bureaus division notes a clinical study of the weight-loss product included 1,436 participants who lost an average of 30.5 pounds in six months as advertised. NAD recommends the firm discontinue testimonials on Sensa's Web site that say people who took Sensa lost 70 or 120 pounds. NAD says the testimonials are misleading when paired with claims based on studies. Manhattan Beach, Calif.-based Sensa says it will consider NAD's recommendation
You may also be interested in...
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.
As part of its response to the coronavirus outbreak, Medicines for Europe has set out a series of policy recommendations that it says could help to mitigate the risks of COVID-19.
The coronavirus COVID-19 outbreak poses a “limited immediate risk” to European production and supplies of off-patent drugs, according to industry association Medicines for Europe. However, if the situation continues for an extended period an “important impact” cannot be ruled out.